Oculogenex, a disruptive ocular gene therapy company, today announced that they won the first place prize at the international Winning Pitch Challenge – Retina 2021. The award was presented to Oculogenex by the directors of the competition, Dr. John Pollack and Dr. David Williams at the virtual event held on February 6, 2021. The event brought together retinal specialists, industry leaders, and investors from around the world to review the latest transformational technologies to treat unmet needs for patients suffering from retinal diseases. The award supports entrepreneurial retinal surgeons and their biotechnology start-ups to accelerate early therapeutic discovery and innovations with the strongest potential for the future benefit of patients, worldwide.
